The Journal of Pediatrics
Volume 154, Issue 2 , Pages 183-188.e3, February 2009

Impact of Pseudomonas and Staphylococcus Infection on Inflammation and Clinical Status in Young Children with Cystic Fibrosis

  • Scott D. Sagel, MD

      Affiliations

    • Department of Pediatrics, The Children's Hospital and University of Colorado Health Sciences Center, Aurora, CO
    • Corresponding Author InformationReprint requests: Scott Sagel, MD, The Children's Hospital, 13123 E 16th Ave, B-395, Aurora, CO 80045
    • ,
  • Ronald L. Gibson, MD, PhD

      Affiliations

    • Department of Pediatrics, Children's Hospital & Regional Medical Center and University of Washington, Seattle, WA
    • ,
  • Julia Emerson, MD, MPH

      Affiliations

    • Department of Pediatrics, Children's Hospital & Regional Medical Center and University of Washington, Seattle, WA
    • ,
  • Sharon McNamara, MN

      Affiliations

    • Department of Pediatrics, Children's Hospital & Regional Medical Center and University of Washington, Seattle, WA
    • ,
  • Jane L. Burns, MD

      Affiliations

    • Department of Pediatrics, Children's Hospital & Regional Medical Center and University of Washington, Seattle, WA
    • ,
  • Jeffrey S. Wagener, MD

      Affiliations

    • Department of Pediatrics, The Children's Hospital and University of Colorado Health Sciences Center, Aurora, CO
    • ,
  • Bonnie W. Ramsey, MD

      Affiliations

    • Department of Pediatrics, Children's Hospital & Regional Medical Center and University of Washington, Seattle, WA
    • Cystic Fibrosis Foundation Therapeutics Development Network Coordinating Center, Children's Hospital and Regional Medical Center, Seattle, WA
    • ,
  • Inhaled Tobramycin in Young Children Study Group

      Affiliations

    • A list of additional members of the Inhaled Tobramycin in Young Children Study Group is available in the appendix (available at www.jpeds.com).
    • ,
  • Cystic Fibrosis Foundation Therapeutics Development Network

Received 1 April 2008; received in revised form 23 June 2008; accepted 1 August 2008. published online 26 September 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supported by grants from the National Institutes of Health (1 RO1 DK 57755-01, -02, K23 RR018611-05, and U01 HL081335-01), US Food and Drug Administration (FD-R-001695-01), Cystic Fibrosis Foundation Therapeutics Development Center Network, Novartis Corporation, and General Clinical Research Centers Program, National Center for Research Resources (MO1-RR00037, RR00046, RR00052, RR00064, RR00069, RR00070, RR00080, RR00188, RR02172, and RR08084). The authors declare no conflicts of interest.

PII: S0022-3476(08)00677-X

doi:10.1016/j.jpeds.2008.08.001

Refers to article:

  • Infection, Inflammation, and the Downward Spiral of Cystic Fibrosis Lung Disease

    Richard B. Moss
    The Journal of Pediatrics February 2009 (Vol. 154, Issue 2, Pages 162-163)

The Journal of Pediatrics
Volume 154, Issue 2 , Pages 183-188.e3, February 2009

Article Tools